High-Throughput Methods for Phosphotyrosine Signaling
New data from The Olsen group
Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. We target the growing need for throughput with robust solutions for clinical and large-scale proteomics in order to bring the community closer to the clinics.
We’d love to hear from you!
Need more information, do not hesitate to contact us.